BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Romero-Masters JC, Huebner SM, Ohashi M, Bristol JA, Benner BE, Barlow EA, Turk GL, Nelson SE, Baiu DC, Van Sciver N, Ranheim EA, Gumperz J, Sherer NM, Farrell PJ, Johannsen EC, Kenney SC. B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. PLoS Pathog 2020;16:e1008365. [PMID: 32059024 DOI: 10.1371/journal.ppat.1008365] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Bahri R, Boyer F, Halabi MA, Chaunavel A, Feuillard J, Jaccard A, Ranger-Rogez S. Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL). Cancers (Basel) 2022;14:2899. [PMID: 35740565 DOI: 10.3390/cancers14122899] [Reference Citation Analysis]
2 Farrell PJ, White RE. Do Epstein–Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease? Biomolecules 2022;12:17. [DOI: 10.3390/biom12010017] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Van Sciver N, Ohashi M, Nawandar DM, Pauly NP, Lee D, Makielski KR, Bristol JA, Tsao SW, Lambert PF, Johannsen EC, Kenney SC. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells. PLoS Pathog 2021;17:e1010045. [PMID: 34748616 DOI: 10.1371/journal.ppat.1010045] [Reference Citation Analysis]
4 Berditchevski F, Fennell E, Murray PG. Calcium-dependent signalling in B-cell lymphomas. Oncogene 2021;40:6321-8. [PMID: 34625709 DOI: 10.1038/s41388-021-02025-8] [Reference Citation Analysis]
5 Su C, Lu F, Soldan SS, Lamontagne RJ, Tang HY, Napoletani G, Farrell PJ, Tempera I, Kossenkov AV, Lieberman PM. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes. PLoS Pathog 2021;17:e1009834. [PMID: 34352044 DOI: 10.1371/journal.ppat.1009834] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Van Sciver N, Ohashi M, Pauly NP, Bristol JA, Nelson SE, Johannsen EC, Kenney SC. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. PLoS Pathog 2021;17:e1009783. [PMID: 34339458 DOI: 10.1371/journal.ppat.1009783] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Frappier L. Epstein-Barr virus: Current questions and challenges. Tumour Virus Res 2021;12:200218. [PMID: 34052467 DOI: 10.1016/j.tvr.2021.200218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 SoRelle ED, Dai J, Bonglack EN, Heckenberg EM, Zhou JY, Giamberardino SN, Bailey JA, Gregory SG, Chan C, Luftig MA. Single-cell RNA-seq reveals transcriptomic heterogeneity mediated by host-pathogen dynamics in lymphoblastoid cell lines. Elife 2021;10:e62586. [PMID: 33501914 DOI: 10.7554/eLife.62586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Rosemarie Q, Sugden B. Epstein-Barr Virus: How Its Lytic Phase Contributes to Oncogenesis. Microorganisms 2020;8:E1824. [PMID: 33228078 DOI: 10.3390/microorganisms8111824] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
10 Li C, Romero-Masters JC, Huebner S, Ohashi M, Hayes M, Bristol JA, Nelson SE, Eichelberg MR, Van Sciver N, Ranheim EA, Scott RS, Johannsen EC, Kenney SC. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice. PLoS Pathog 2020;16:e1008590. [PMID: 32542010 DOI: 10.1371/journal.ppat.1008590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]